Lexaria Bioscience Corp.: Clinical Trials

3 trials sponsored by Lexaria Bioscience Corp., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Early Phase 11Unknown 1

Follow Lexaria Bioscience Corp.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Arm 1 - DehydraTECH-CBD alone, Arm 2 - DehydraTECH-semaglutide alone, Arm 3 - DehydraTECH-CBD in combination with DehydraTECH-semaglutide - Type2diabetes
Phase 1CompletedLexaria Bioscience Corp.1482024-12-042026-01-12
Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients
Cannabidiol, Placebo - Hypertension
Phase 1CompletedUniversity of Split, School of Medicine702022-04-082023-05-16
Cannabinoid Supplementation on Vascular and Cognitive Function
Cannabidiol supplement - Diet Modification
Early Phase 1UnknownUniversity of British Columbia242018-01-012019-10-23

Conditions studied

Hypertension (1)

Interventions

Cannabidiol (1)  ·  Single Person (1)  ·  semaglutide (1)

Countries

Australia (1)  ·  Canada (1)  ·  Croatia (1)

Top investigators

Zeljko Dujic, MD, PhD (1)

Results publications

PMID 31512143, PMID 37093160